Do we need new trials of procalcitonin-guided antibiotic therapy? A response
Crit Care
.
2018 Mar 23;22(1):83.
doi: 10.1186/s13054-018-2008-y.
Authors
Jos A H van Oers
1
,
Maarten W Nijsten
2
,
Dylan W de Lange
3
Affiliations
1
Department of Intensive Care Medicine, Elisabeth Tweesteden Ziekenhuis, P.O. Box 90151, 5000 LC, Tilburg, the Netherlands. jah.vanoers@etz.nl.
2
Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
3
Department of Intensive Care Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
PMID:
29566764
PMCID:
PMC5865370
DOI:
10.1186/s13054-018-2008-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents
Biomarkers
Calcitonin Gene-Related Peptide
Calcitonin*
Humans
Protein Precursors*
Substances
Anti-Bacterial Agents
Biomarkers
Protein Precursors
Calcitonin
Calcitonin Gene-Related Peptide